Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors

  • Published: Dec 24, 2008
  • Earliest Priority: Jun 13 2007
  • Family: 19
  • Cited Works: 1
  • Cited by: 12
  • Cites: 7
  • Additional Info: Full text

This disclosure relates generally to methods and pharmaceutical compositions useful in treating pulmonary hypertension. In one embodiment, for example, the disclosure provides a method for treating pulmonary hypertension comprising administering a therapeutically effective dose of a carbonic anhydrase inhibitor to a patient in need of treatment. The disclosure finds utility in the fields of medicine and pharmacology.

CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Dec 24, 2008
  • Application: May 30, 2008
    WO US 2008/0006850 W
  • Priority: Jun 13, 2007
    US US 81830607 A

Download Citation

Sign in to the Lens